Back
Enanta Pharmaceuticals Vs. Theriva Biologics Industry Stock Comparison
Sell
25
ENTA
Enanta Pharmaceuticals
Last Price:
11.29
Seasonality Move:
7.66%
Buy
74
TOVX
Theriva Biologics
Last Price:
3.89
Seasonality Move:
-14.85%
Sell
25
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy, Sell or Hold?
- The current Enanta Pharmaceuticals [ENTA] share price is $11.30. The Score for ENTA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ENTA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Theriva Biologics (TOVX)
is a Buy
Is Theriva Biologics a Buy, Sell or Hold?
- The current Theriva Biologics [TOVX] share price is $3.79. The Score for TOVX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- TOVX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ENTA Stock Price Chart
What is Enanta Pharmaceuticals's stock price today?
-
The Enanta Pharmaceuticals share price today is $11.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing selling pressure, which indicates risk of future bearish movement.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $3.79
The current trend is moderately bullish and TOVX is experiencing slight selling pressure.
ENTA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 36.26 | Sell |
Chaikin Money Flow: | -356337 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.74 - 12.88) | Sell |
Bollinger Bands (100): | (11.92 - 14.28) | Sell |
TOVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.74 | Buy |
Relative Strength Index (14 RSI): | 45.64 | Sell |
Chaikin Money Flow: | -9914 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.09 - 4.65) | Buy |
Bollinger Bands (100): | (-0.5 - 2.36) | Buy |
ENTA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.87 | Sell |
20-day SMA: | 12.28 | Sell |
50-day SMA: | 13.32 | Sell |
200-day SMA: | 12.98 | Sell |
8-day EMA: | 11.74 | Sell |
20-day EMA: | 12.15 | Sell |
50-day EMA: | 12.74 | Sell |
200-day EMA: | 14.3 | Sell |
TOVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.89 | Sell |
20-day SMA: | 3.55 | Buy |
50-day SMA: | 1.56 | Buy |
200-day SMA: | 0.7 | Buy |
8-day EMA: | 3.87 | Sell |
20-day EMA: | 3.31 | Buy |
50-day EMA: | 2.13 | Buy |
200-day EMA: | 0.97 | Buy |
Enanta Pharmaceuticals Earnings Growth & ENTA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.25 per share, an increase this year of $2.01 per share, and an increase next year of $0.23 per share.
Theriva Biologics Earnings Growth & TOVX Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
Enanta Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Theriva Biologics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |